Capillary Immunoassay Quantification of Broad Glycoconjugate Signals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current capillary-based immunoassay methods fail to provide reliable quantitative data for glycoconjugates, particularly bioconjugates, which generate broad signals with non-resolved peaks, and lack accurate identification and absolute quantification of closely-related glycoconjugates differing in polysaccharide components.

Innovation Solution

A method using a capillary-based immunoassay system with a computer program that integrates the entire signal area by setting molecular weight range limits, subtracts background signals, and generates a calibration curve for accurate quantification of glycoconjugates, especially bioconjugates, by employing glycan-specific antibodies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If capillary-based immunoassay methods are used for glycoconjugate analysis, then automation and analysis time are improved, but reliable quantification of broad signals with non-resolved peaks deteriorates

Engineering Contradiction:
Improveautomation and analysis timeVSAvoidquantification accuracy of broad signals
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent segments the broad signal into multiple individual peak areas through computational deconvolution. The computer program divides the integrated signal area into distinct peak components, allowing accurate quantification of each glycoconjugate variant even when they appear as a broad unresolved envelope in the capillary electrophoresis data.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a computer program with specialized algorithms as an intermediary between the capillary-based immunoassay system and the quantification process. This software mediator performs background subtraction, signal integration, and peak deconvolution to extract accurate quantitative data from broad signals that cannot be directly measured.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If standard capillary-based immunoassay methods are used, then manual labor is reduced, but identification and quantification of closely-related glycoconjugates deteriorates

Engineering Contradiction:
Improvemanual labor reductionVSAvoididentification and quantification of closely-related glycoconjugates
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent implements dynamic, adjustable parameters in the computer program including variable integration limits, adaptive background subtraction regions, and flexible peak deconvolution algorithms. These dynamic settings allow the system to adapt to different signal shapes and resolutions, enabling accurate differentiation of closely-related glycoconjugates without increasing manual intervention.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent incorporates feedback mechanisms where the computer program iteratively refines peak area calculations based on the detected signal characteristics. The system uses the integrated signal information to adjust and optimize the segmentation of individual peak areas, providing accurate quantification of closely-related glycoconjugates that would otherwise be indistinguishable.

Inventive Principle:
Principle #23Feedback

3Device complexity

If broad signal integration is attempted without background subtraction, then quantification process is simplified, but measurement accuracy deteriorates

Engineering Contradiction:
Improvequantification process complexityVSAvoidquantification accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent performs background subtraction as a preliminary step before integrating the signal area. The computer program automatically identifies and subtracts the background signal level from the total signal, ensuring that only the analyte-specific signal is integrated. This preliminary action removes a major source of quantification error while the automated algorithm keeps the process straightforward.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise identification and absolute quantification of glycoconjugates, including bioconjugates, even with broad signals, by integrating the whole signal area and subtracting background, thereby overcoming limitations of existing methods.

Implementation Method 1

In such methods, the different components of a sample are separated within a capillary

Methodology Applied
Scientific EffectCapillary electrophoresis: Capillary Electrophoresis

Implementation Method 2

detected by means of a specific antibody

Methodology Applied
Scientific EffectAntibody-antigen binding:

Data Source

PatentUS20250377362A1Analytical method for glycogonjugates using a capillary-based immunoassay system
Publication Date: 2025.12.11 JANSSEN PHARMACEUTICALS INC
  • US20250377362A1 patent drawing
  • US20250377362A1 patent drawing
  • US20250377362A1 patent drawing

AI summary

The invention provides analytical methods for identifying and quantifying complex glycoconjugate compositions, in particular for the analysis of a glycoconjugate in a sample comprising at least 4 glycoconjugates.